These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 20689436)

  • 41. Elevated donor troponin levels are associated with a lower frequency of allograft vasculopathy.
    Miller WL; Edwards BS; Kremers WK; Kushwaha SS; McGregor CG; Daly RC; Jaffe AS
    J Heart Lung Transplant; 2005 Dec; 24(12):2075-8. PubMed ID: 16364852
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cardiac allograft vasculopathy after cardiac transplantation and hormone therapy: positive effects?
    Lange V; Renner A; Sagstetter M; Harms H; Elert O
    Transplantation; 2006 Jul; 82(2):234-40. PubMed ID: 16858287
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Follow-up study on the utility of von Willebrand factor levels in the diagnosis of cardiac allograft vasculopathy.
    Martínez-Dolz L; Almenar L; Reganon E; Vila V; Chamorro C; Andrés L; Martínez-Sales V; Moro J; Agüero J; Sánchez-Lázaro I; Salvador A
    J Heart Lung Transplant; 2008 Jul; 27(7):760-6. PubMed ID: 18582806
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Perspectives on cardiac allograft vasculopathy.
    Young JB
    Curr Atheroscler Rep; 2000 May; 2(3):259-71. PubMed ID: 11122752
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Pediatric coronary allograft vasculopathy--a review of pathogenesis and risk factors.
    Schumacher KR; Gajarski RJ; Urschel S
    Congenit Heart Dis; 2012; 7(4):312-23. PubMed ID: 22176627
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cardiac allograft vasculopathy: a review.
    Weis M; von Scheidt W
    Circulation; 1997 Sep; 96(6):2069-77. PubMed ID: 9323100
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cardiac allograft vasculopathy: current review and future research directions.
    Pober JS; Chih S; Kobashigawa J; Madsen JC; Tellides G
    Cardiovasc Res; 2021 Nov; 117(13):2624-2638. PubMed ID: 34343276
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cardiac allograft vasculopathy--the cellular attack.
    Hutchinson IV
    Z Kardiol; 2000; 89 Suppl 9():IX/16-20. PubMed ID: 11151784
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Immunological and Fibrotic Mechanisms in Cardiac Allograft Vasculopathy.
    Jansen MA; Otten HG; de Weger RA; Huibers MM
    Transplantation; 2015 Dec; 99(12):2467-75. PubMed ID: 26285017
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Role of antibodies in transplant-associated cardiac allograft vasculopathy.
    Rose ML
    Z Kardiol; 2000; 89 Suppl 9():IX/11-5. PubMed ID: 11151778
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Innate immunity and cardiac allograft rejection.
    Millington TM; Madsen JC
    Kidney Int Suppl; 2010 Dec; (119):S18-21. PubMed ID: 21116311
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effects of immunoglobulin to prevent coronary allograft vasculopathy in heart transplantation.
    Suzuki J; Ogawa M; Hirata Y; Nagai R; Isobe M
    Expert Opin Ther Targets; 2012 Aug; 16(8):783-9. PubMed ID: 22762198
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Altered alloimmune response toward grafts from brain-dead donors in chronic rat cardiac allograft rejection.
    Wilhelm MJ; Pratschke J; Laskowski IA; Paz DM; Hancock WW; Tilney NL
    Transplant Proc; 2001; 33(1-2):366-7. PubMed ID: 11266864
    [No Abstract]   [Full Text] [Related]  

  • 54. Cardiac allograft vasculopathy: a complex multifactorial sequela of heart transplantation.
    Segura AM; Buja LM
    Tex Heart Inst J; 2013; 40(4):400-2. PubMed ID: 24082368
    [No Abstract]   [Full Text] [Related]  

  • 55. Cardiac allograft vasculopathy--problem and model.
    von Scheidt W
    Z Kardiol; 2000; 89 Suppl 9():IX/2-5. PubMed ID: 11151785
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Alloantibodies restore cardiac allograft rejection to IgKO mice.
    Wasowska BA; Qian Z; Cangello DL; Van Tran K; Layton JL; Sanfilippo F; Baldwin WM
    Transplant Proc; 2001; 33(1-2):317. PubMed ID: 11266837
    [No Abstract]   [Full Text] [Related]  

  • 57. Cardiac Allograft Vasculopathy: The Enduring Enemy of Cardiac Transplantation.
    Nikolova AP; Kobashigawa JA
    Transplantation; 2019 Jul; 103(7):1338-1348. PubMed ID: 31241553
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Immune mechanisms of cardiac allograft vasculopathy: an update.
    Hosenpud JD
    Transpl Immunol; 1993; 1(4):237-49. PubMed ID: 8081780
    [No Abstract]   [Full Text] [Related]  

  • 59. Role of apoptosis in cardiac allograft vasculopathy.
    Kabelitz D
    Z Kardiol; 2000; 89 Suppl 9():IX/21-3. PubMed ID: 11151786
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Mechanism of arterial remodeling in chronic allograft vasculopathy.
    Zheng Q; Liu S; Song Z
    Front Med; 2011 Sep; 5(3):248-53. PubMed ID: 21964706
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.